The official website of National Health and Family Planning Commission of the P.R.C. (NHFPC) issued Publicity on Drug Varieties for Priority Examination planned to be recommended by Major Science and Technology Projects for Creation of Major New Drugs on January 12. According to it, 18 drug varieties supported by the special projects such as Famitinib, BGB-283 and Hydroxyl piperidyl ketone hydrochloride from multiple R&D units such as Hengrui Medicine, BeiGene and Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences are the varieties for priority examination.
|
List of drugs for priority examination planned to be recommended by special projects for Chinese new drugs |
||||
|
Serial No. |
Variety name |
Item |
R&D unit |
Expert opinion |
|
1 |
Famitinib |
Applied for clinical research |
Jiangsu Hengrui Medicine Co., Ltd. |
Recommended |
|
2 |
BGB-283 |
Applied for clinical research |
BeiGene (Beijing) Co., Ltd. |
Recommended |
|
3 |
Hydroxyl piperidyl ketone hydrochloride |
Applied for clinical research |
Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences |
Recommended |
|
4 |
Chlorobenzene piperidone hydrochloride |
Applied for clinical research |
Beijing Sciecure Pharmaceutical Co., Ltd. Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences |
Recommended |
|
5 |
SKLB1028 |
Applied for clinical research |
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co. Ltd. Sichuan University |
Recommended |
|
6 |
Mitoxantrone hydrochloride injection for lymphatic tracer |
Applied for clinical research |
Kangmaisi Pharmaceutical Co., Ltd. in Benxi Economic Development Zone |
Recommended |
|
7 |
Nitrone piperazine |
Applied for clinical research |
Guangzhou Magpie Pharmaceuticals Co., Ltd. |
Recommended |
|
8 |
C118P |
Applied for clinical research |
Nanjing Sanhome Pharmaceutical Co., Ltd. |
Recommended |
|
9 |
Berberine hydrochloride tablets |
Applied for clinical research |
Northeast Pharmaceutical Group Co., Ltd. |
Recommended |
|
10 |
Busulfan injection |
Applied for production |
China Resources Double-crane Pharmaceutical Co., Ltd. |
Recommended |
|
11 |
Recombinant human vascular endothelial growth factor receptor-Fc fusion protein for injection |
Clinical supplementary application |
Chengdu Kanghong Biotechnology Co. Ltd. |
Recommended |
|
12 |
Recombinant staphylokinase for injection-hirudin fusion protein |
Applied for clinical research |
Institute of Radiation Medicine, Academy Of Military Medical Sciences of the Chinese PLA, and Wuhan Guanggu Humanwell Biomedical Pharmaceutical Co., Ltd. |
Recommended |
|
13 |
Recombinant pancreatic glucagon-like peptide-1 receptor agonist |
Clinical supplementary application |
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co. Ltd. |
Recommended |
|
14 |
Lecithinized recombinant human copper, zinc-superoxide dismutase for injection |
Applied for clinical research |
Beijing Tide Pharmaceutical Co., Ltd. |
Recommended |
|
15 |
Recombinant fully-human monoclonal antibody against RANKL for injection |
Applied for clinical research |
Jiangsu T-mab BioPharma |
Recommended |
|
16 |
SHR-A1201 for injection |
Applied for clinical research |
Jiangsu Hengrui Medicine Co., Ltd. Shanghai Hengrui Pharmaceutical Co., Ltd. |
Recommended |
|
17 |
Insulin aspart |
Applied for production |
Gan & Lee Pharmaceuticals |
Recommended |
|
18 |
Recombinant human insulin |
Applied for clinical research |
Hefei Tianmai Biotechnology Development Co., Ltd. |
Recommended |
